GlobalMed Announces Partnership With Canary Speech To Amplify Behavioral Health Diagnostic Power
Summary
GlobalMed will serve as an authorized reseller and federal partner for Canary Speech, embedding Canary's AI-powered vocal biomarker technology into GlobalMed's eNcounter telehealth platform. The integration enables real-time voice-based screening and objective decision support by analyzing over 2,500 digital biomarkers to detect stress, depression, mood changes, and neurodegenerative signals. GlobalMed plans to deploy the solution across U.S. federal healthcare systems (including VA and DoD) to accelerate behavioral health interventions and improve outcomes for underserved populations. The API-first, HIPAA-compliant offering aims to fit into existing clinical workflows without disruption and treat voice as a new vital sign for earlier detection and monitoring.